Efficacy of Immediate Versus Staged Complete Revascularization in Patients With NSTE-ACS and Multivessel Disease (FUTURE II)

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1904 participants.

Also called NCT07343076

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,904 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07343076
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07343076. Randomized; single masking; primary purpose treatment. Start 2026-02-28 (anticipated); primary completion 2029-02-28 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy of Immediate Versus Staged Complete Revascularization in Patients With NSTE-ACS and Multivessel Disease (FUTURE II)
Condition
NSTEMI
Condition
NSTEMI - Non-ST Segment Elevation MI
Condition
Non-ST-elevation Acute Coronary Syndrome
Condition
NSTE-ACS (NSTEMI and UA)
Intervention (Device)
Immediate Complete Revascularization
Intervention (Device)
Staged Complete Revascularization
Lead sponsor
RenJi Hospital (class: other)
Collaborator
People's Hospital of Xinjiang Uygur Autonomous Region (class: other)
Collaborator
LanZhou University (class: other)

Record details

Record id
cardio:ct-nct07343076
Content hash
c1c77b4caaa33255658e0983a981196dd884accea967ffd3e365425de39ad1fd